2024 SITC-NCI AI in IO: Computational Immuno-oncology Webinar Series

Course 2: AI in Personalized Immunotherapies 

05-22-2024 09:56

On May 15, 2024, the Society for Immunotherapy of Cancer (SITC) in partnership with the National Cancer Institute (NCI) held the second computational immuno-oncology webinar of series 4. The recording of the second webinar "Course 2 - AI in Personalized Immunotherapies: AI in Immuno-oncology" is available below.

Webinar Faculty

  • Presenter: Rachel Karchin, PhD  Johns Hopkins School of Medicine
  • Moderator: Carsten Krieg, PhD Medical University of South Carolina


Program Information

In partnership with and partial funding by the National Cancer Institute (NCI), the Society for Immunotherapy of Cancer (SITC) is launching our fourth "SITC-NCI Computational Immuno-oncology Webinar Series" throughout May-December 2024. This year’s series will focus specifically on the application of artificial intelligence (AI) in the field of immuno-oncology (IO). As such, the series has been rebranded to “AI in IO: SITC-NCI Computational Immuno-oncology Webinar Series.” Organized by the SITC Big Data and Data Sharing Committee, these nine free-to-attend digital events will help individual research labs to embrace the computational challenges of analyzing and integrating diverse assay data across the spectrum of immuno-oncology using AI. The goal of this special series is to explore the exciting applications and promising implications of the rapidly advancing field of AI for immuno-oncology. All webinars in this series will take place live and be made available in their entirety on the SITC ConnectED platform as enduring materials

#PresentationSlides#RecordedWebinar
#2024

Statistics
0 Favorited
49 Views
2 Files
0 Shares
10 Downloads
Attachment(s)
mp4 file
AI in Personalized Immunotherapies - Recorded Webinar   316.27 MB   1 version
Uploaded - 05-22-2024
pdf file
AI in Personalized Immunotherapies - Slides   10.89 MB   1 version
Uploaded - 05-22-2024

Related Entries and Links

No Related Resource entered.